Gables Capital Management Inc. Biogen Inc. Transaction History

Gables Capital Management Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	SELL	$253.3 - $285.89 $26,849 - $30,304	-106 Reduced 77.94%	30 $7,000
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $2,429 - $2,846	-10 Reduced 6.85%	136 $38,000
Q1 2020 May 07, 2020	BUY	$268.85 - $341.04 $28,498 - $36,150	106 Added 265.0%	146 $46,000
Q1 2019 Apr 30, 2019	SELL	$216.71 - $338.96 $258,318 - $404,040	-1,192 Reduced 96.75%	40 $9,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $6,962 - $8,818	-25 Reduced 1.99%	1,232 $371,000
Q3 2018 Nov 05, 2018	SELL	$293.51 - $383.83 $14,675 - $19,191	-50 Reduced 3.83%	1,257 $0
Q2 2018 Aug 03, 2018	SELL	$257.52 - $306.91 $5,407 - $6,445	-21 Reduced 1.58%	1,307 $383,000
Q1 2018 May 17, 2018	BUY	$260.13 - $367.91 $345,452 - $488,584	1,328 New	1,328 $364,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Gables Capital Management Inc., based on Form 13F filings with the SEC.

Stay updated on Gables Capital Management Inc. with notifications on news.